Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding the mechanism by which Gd(III) coiled coils achieve magnetic resonance relaxivity - a study into the water coordination chemistry.

Dalton transactions (Cambridge, England : 2003)·2023
Same author

In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model.

Journal of inorganic biochemistry·2009
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
13:21

Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging

Published on: July 21, 2011

15.4K

De Novo Designed Imaging Agents Based on Lanthanide Peptides Complexes.

A F A Peacock1

  • 1School of Chemistry, University of Birmingham, Edgbaston, United Kingdom.

Methods in Enzymology
|September 3, 2016
PubMed
Summary

Lanthanide complexes with peptides and proteins show promise for medical imaging. Designing specific protein structures enhances their use in luminescence and magnetic resonance imaging for clinical applications.

Keywords:
Coiled coilsCoordination chemistryDe novo designGadoliniumImagingLanthanideLuminescenceMRIPeptide

More Related Videos

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.8K
Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

15.1K

Related Experiment Videos

Last Updated: Mar 15, 2026

Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
13:21

Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging

Published on: July 21, 2011

15.4K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.8K
Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

15.1K

Area of Science:

  • Biophysical Chemistry
  • Chemical Biology
  • Biotechnology

Background:

  • Lanthanide complexes are explored for biomedical imaging due to unique luminescent and paramagnetic properties.
  • Peptide and protein scaffolds offer versatile platforms for chelating lanthanides, enhancing stability and targeting.
  • Current challenges include optimizing lanthanide coordination and ensuring biocompatibility for clinical translation.

Purpose of the Study:

  • To review lanthanide peptide/protein complexes for imaging applications.
  • To highlight the potential of de novo protein design for creating novel lanthanide-binding sites.
  • To discuss requirements and challenges for clinical adoption of these agents.

Main Methods:

  • Focus on de novo design of coiled coils and miniature protein scaffolds.
  • Integration of lanthanide-binding sites into designed protein architectures.
  • Analysis of lanthanide coordination chemistry within peptide/protein frameworks.

Main Results:

  • Demonstration of tailored protein structures for lanthanide complexation.
  • Exploration of luminescence and magnetic resonance imaging capabilities.
  • Identification of key design principles for effective lanthanide-peptide/protein agents.

Conclusions:

  • Engineered lanthanide-peptide/protein complexes offer significant potential as advanced imaging agents.
  • De novo protein design is a powerful strategy for developing targeted and efficient lanthanide-based imaging tools.
  • Addressing coordination and clinical challenges is crucial for realizing the full potential of these agents in medical diagnostics.